Virupaksha Organics Ltd.: Leading Manufacturer of Escitalopram Oxalate
Virupaksha Organics Ltd. continues to strengthen its position in the global pharmaceutical industry as a trusted manufacturer of Escitalopram Oxalate, an essential active pharmaceutical ingredient (API) used in the treatment of depression and anxiety disorders. Escitalopram Oxalate is the key component in widely prescribed antidepressant medications, making its consistent and high-quality production critical to improving mental health outcomes globally.
With cutting-edge manufacturing facilities in Telangana, India, Virupaksha Organics adheres to the highest standards of quality, safety, and compliance. The company’s production facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, reflecting its commitment to maintaining best practices in pharmaceutical manufacturing and environmental sustainability.
Virupaksha’s focus on innovation, research, and excellence ensures that its Escitalopram Oxalate meets international regulatory standards, allowing the company to supply this crucial API to pharmaceutical companies worldwide. With a robust R&D infrastructure and advanced quality control systems, Virupaksha ensures the cost-effective and high-purity production of Escitalopram Oxalate, contributing to improved mental health treatments across the globe.
As Virupaksha Organics continues to expand its global footprint, it remains dedicated to delivering top-tier APIs like Escitalopram Oxalate that contribute to advancing healthcare and improving lives. Through its emphasis on quality, sustainability, and customer satisfaction, the company continues to be a trusted partner for pharmaceutical firms worldwide.
